Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens
Lourdes Villalba(National Institutes of Health), Frederick W. Miller(National Institutes of Health), Richard L. Leff, Bryce Thornton(National Institutes of Health Clinical Center), Paul H. Plötz(National Institutes of Health), Jeffrey B. Sherman(National Institutes of Health), Elizabeth M. Adams(National Institutes of Health), Suzanne H. Burgess(National Institutes of Health Clinical Center)
Cited by 176
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395